On Friday, Chromadex Corp (NASDAQ: CDXC) opened higher 3.02% from the last session, before settling in for the closing price of $2.65. Price fluctuations for CDXC have ranged from $1.25 to $4.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Consumer Defensive Sector giant saw their annual sales surged by 22.27% over the last five years. Company’s average yearly earnings per share was noted 78.57% at the time writing. With a float of $48.51 million, this company’s outstanding shares have now reached $74.98 million.
The firm has a total of 106 workers. Let’s measure their productivity.
Chromadex Corp (CDXC) Insider Activity
A key investor’s attitude towards the stock of the Packaged Foods industry is another important factor to consider. The insider ownership of Chromadex Corp is 35.79%, while institutional ownership is 17.55%. The most recent insider transaction that took place on Dec 01 ’23, was worth 7,050. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $1.41, taking the stock ownership to the 27,436 shares.
Chromadex Corp (CDXC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 78.57% per share during the next fiscal year.
Chromadex Corp (NASDAQ: CDXC) Trading Performance Indicators
Check out the current performance indicators for Chromadex Corp (CDXC). In the past quarter, the stock posted a quick ratio of 1.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.48. Likewise, its price to free cash flow for the trailing twelve months is 46.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.05, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.06 in one year’s time.
Technical Analysis of Chromadex Corp (CDXC)
Analysing the last 5-days average volume posted by the [Chromadex Corp, CDXC], we can find that recorded value of 1.59 million was better than the volume posted last year of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 43.77%. Additionally, its Average True Range was 0.27.
During the past 100 days, Chromadex Corp’s (CDXC) raw stochastic average was set at 39.81%, which indicates a significant decrease from 41.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.34% in the past 14 days, which was lower than the 96.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.19, while its 200-day Moving Average is $2.15. Now, the first resistance to watch is $2.83. This is followed by the second major resistance level at $2.93. The third major resistance level sits at $3.06. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.47. Should the price break the second support level, the third support level stands at $2.37.
Chromadex Corp (NASDAQ: CDXC) Key Stats
There are currently 75,539K shares outstanding in the company with a market cap of 206.22 million. Presently, the company’s annual sales total 83,570 K according to its annual income of -4,940 K. Last quarter, the company’s sales amounted to 22,150 K and its income totaled -490 K.
